Prostate/Genitourinary (GU) Cancer
Genitourinary cancers may be the broadest and most common of all malignancies, and includes everything from the rare but curable testicular cancer to prostate cancer, one of the most common types of cancer with a range of patient outcomes.
There are 60% more cases of prostate cancer in African-American men than white men. African-American men are also more than twice as likely to die from prostate cancer. The reasons why are not known. But some risk factors may play a part. These include differences in diet, workplace, hormones, and genes.
More than 233,000 men in the U.S. will get prostate cancer in 2015. It is the most common cancer in men, not including skin cancer. Nearly two-thirds of these men will be age 65 or older.
Nearly all men diagnosed with prostate cancer survive at least 5 years. And 99% survive at least 10 years. Ninety-four percent survive at least 15 years. This includes all stages and grades of prostate cancer. It also includes all treatments.
Prostate cancer is the second leading cause of cancer death in men in the U.S., after lung cancer.
The genitourinary tract traditionally includes the kidneys, the bladder, the tubes that collect and drain urine from the kidneys and drain it into the bladder (the ureters), the tube that drains urine from the bladder to the outside (the urethra), and specifically in men, the testicles and the prostate. The prostate is an accessory sex gland necessary for reproduction. Also classified as genitourinary cancers, are cancers that develop on the penis or in the adrenal glands. The adrenal glands are small hormone-producing glands, which are located on the top of each kidney.